Mexico offers a more immediate purchasing signal. The federal government says it achieved nearly MXN70bn in savings on medicines through direct purchases from manufacturers and new tenders. Two things stand out there. First, central medicine buying is active. Second, the source points to both direct purchases and tenders in the same market, which matters when suppliers are deciding how to position themselves.